Oncology & Cancer

New path to treat advanced triple-negative breast cancer

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...

Oncology & Cancer

New therapeutic target for hematologic malignancies identified

Inhibition of Ubiquitin Specific Peptidase 47 (USP47) was identified as a novel therapeutic target for hematologic malignancies bearing mutant oncoprotein EZH2, according to scientists from the Hefei Institutes of Physical ...

Medical research

Gene expression could ring early kidney disease alarm

Biomedical engineers at Duke University have developed a method to study how key cells in the kidneys become injured and deformed. The new model has revealed a significant mechanism behind severe kidney disease and pointed ...

Oncology & Cancer

Identification of a novel therapeutic target in multiple myeloma

Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. Proteasome inhibitors, the therapeutic backbone of current treatments, are very effective in treating newly diagnosed ...

Oncology & Cancer

New microscope technology can detect tumor cells in the blood

Detection of circulating tumor cells (CTCs) in the blood of cancer patients is of intense interest to medical oncologists. The promise of being able to detect such rare cells consistently and reproducibly has attracted considerable ...

page 26 from 40